Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Jan;70(1):22–27. doi: 10.1136/jnnp.70.1.22

Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment

A Cappa 1, M Calcagni 1, G Villa 1, A Giordano 1, C Marra 1, G De Rossi 1, M Puopolo 1, G Gainotti 1
PMCID: PMC1763484  PMID: 11118243

Abstract

OBJECTIVES—Patients with Alzheimer's disease (AD) showing a selective impairment of episodic and semantic memory have recently been classified as affected by focal temporal lobe dysfunction (FTLD) and considered as a distinct subgroup of patients affected by a particular form of AD. The aim was to compare the cerebral perfusion of patients with AD with FTLD and patients with AD with the more typical profile of diffuse cognitive impairment (dAD).
METHODS—Ten patients with AD with FTLD, 14 patients with AD with dAD, and 12 normal controls were studied. All the 24 patients with AD underwent a complete neuropsychological assessment. SPECT examination with [99mTc]-HMPAO, using a four head brain dedicated tomograph, was performed in patients and controls. Tracer uptake was quantified in 27 regions of interest (ROIs), including lateral and mesial temporal areas. Mean counts in the 27 ROIs of controls, patients with FTLD and those with dAD were compared using an ANOVA for repeated measures with Bonferroni's correction. A logistic regression analysis, followed by a receiver operating characteristic (ROC) analysis, was also applied to select SPECT patterns which significantly differentiated patients with FTLD and those with dAD.
RESULTS—Two scintigraphic patterns of abnormalities, shaping a double dissociation between the FTLD and dAD groups, emerged: a bilateral mesial temporal hypoperfusion, characteristic of FTLD and a posterior parietal (and temporal parietal) hypoperfusion characteristic of patients with dAD.
CONCLUSIONS—These scintigraphic findings provide further support to the hypothesis that FTLD is not a mere stage but a distinct anatomoclinical form of AD. The combination of neuropsychological tests and [99mTc]-HMPAO SPECT may be very useful in identifying patients with FTLD from the wider group of patients with dAD. This issue is particularly worthwhile, as there is increasing evidence that patients with FTLD have a slower rate of cognitive decline.



Full Text

The Full Text of this article is available as a PDF (154.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butters M. A., Lopez O. L., Becker J. T. Focal temporal lobe dysfunction in probable Alzheimer's disease predicts a slow rate of cognitive decline. Neurology. 1996 Mar;46(3):687–692. doi: 10.1212/wnl.46.3.687. [DOI] [PubMed] [Google Scholar]
  2. Carlesimo G. A., Caltagirone C., Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol. 1996;36(6):378–384. doi: 10.1159/000117297. [DOI] [PubMed] [Google Scholar]
  3. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  4. Frlich L., Eilles C., Ihl R., Maurer K., Lanczik M. Stage-dependent reductions of regional cerebral blood flow measured by HMPAO-SPECT in dementia of Alzheimer type. Psychiatry Res. 1989 Sep;29(3):347–350. doi: 10.1016/0165-1781(89)90085-1. [DOI] [PubMed] [Google Scholar]
  5. Haxby J. V., Grady C. L., Koss E., Horwitz B., Heston L., Schapiro M., Friedland R. P., Rapoport S. I. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol. 1990 Jul;47(7):753–760. doi: 10.1001/archneur.1990.00530070043010. [DOI] [PubMed] [Google Scholar]
  6. Hodges J. R., Patterson K. Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications. Neuropsychologia. 1995 Apr;33(4):441–459. doi: 10.1016/0028-3932(94)00127-b. [DOI] [PubMed] [Google Scholar]
  7. Jorm A. F. Subtypes of Alzheimer's dementia: a conceptual analysis and critical review. Psychol Med. 1985 Aug;15(3):543–553. doi: 10.1017/s003329170003141x. [DOI] [PubMed] [Google Scholar]
  8. Martin A., Brouwers P., Lalonde F., Cox C., Teleska P., Fedio P., Foster N. L., Chase T. N. Towards a behavioral typology of Alzheimer's patients. J Clin Exp Neuropsychol. 1986 Oct;8(5):594–610. doi: 10.1080/01688638608405178. [DOI] [PubMed] [Google Scholar]
  9. O'Brien J. T., Eagger S., Syed G. M., Sahakian B. J., Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1182–1187. doi: 10.1136/jnnp.55.12.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ohnishi T., Hoshi H., Nagamachi S., Jinnouchi S., Flores L. G., 2nd, Futami S., Watanabe K. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med. 1995 Jul;36(7):1163–1169. [PubMed] [Google Scholar]
  11. Perani D., Di Piero V., Vallar G., Cappa S., Messa C., Bottini G., Berti A., Passafiume D., Scarlato G., Gerundini P. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med. 1988 Sep;29(9):1507–1514. [PubMed] [Google Scholar]
  12. Tran Dinh Y. R., Mamo H., Cervoni J., Caulin C., Saimot A. C. Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. J Nucl Med. 1990 Oct;31(10):1601–1607. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES